Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long Interspersed Nuclear Element-1 Open Reading Frame 1 protein (LINE-1 ORF1p) is a 40 kDa RNA-binding protein and nucleic acid chaperone encoded by the LINE-1 retrotransposon, the only active autonomous mobile genetic element in the human genome. It plays a critical role in the LINE-1 life cycle by binding to LINE-1 mRNA to form a ribonucleoprotein (RNP) complex, which is essential for the transport and integration of new genetic copies. While typically silenced in healthy adult somatic tissues through epigenetic mechanisms, ORF1p is highly overexpressed in a vast majority of human cancers, including pancreatic, colorectal, and ovarian malignancies. In the tumor microenvironment, ORF1p has been shown to shield repetitive RNAs from innate immune sensors like RIG-I and MAVS, thereby suppressing anti-tumor immune responses and promoting viral mimicry evasion. Due to its high tumor specificity, ORF1p is an emerging pan-cancer biomarker for early detection and monitoring via liquid biopsy. Therapeutic strategies targeting ORF1p include small molecule inhibitors of its chaperone activity, such as the experimental compounds B7 and C1, as well as DNA vaccines and targeted protein degraders. These interventions aim to inhibit tumor growth, restore innate immune signaling, and address the chronic inflammation associated with LINE-1 activation in aging and autoimmune diseases.
Inhibition of nucleic acid chaperone activity, suppression of protein expression, and induction of immune responses via vaccination or targeted degradation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long Interspersed Nuclear Element-1 Open Reading Frame 1 protein (LINE-1 ORF1p).